Cyfuse Biomedical K.K. (TYO:4892)
Japan · Delayed Price · Currency is JPY 567.00
-3.00 (-0.53%)
Aug 27, 2026, 2:03 PM JST
Cyfuse Biomedical K.K. Market Cap
Cyfuse Biomedical K.K. has a market cap or net worth of 5.68 billion as of August 26, 2026. Its market cap has increased by 7.02% in one year.
Market Cap
5.68B
Enterprise Value
3.52B
Revenue
305.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
567.00
ChartMarket Cap Chart
Since December 1, 2022, Cyfuse Biomedical K.K.'s market cap has decreased from 13.00B to 5.68B, a decrease of -56.32%. That is a compound annual growth rate of -19.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 5.68B | 0.15% |
| Dec 30, 2025 | 5.67B | 54.23% |
| Dec 30, 2024 | 3.68B | -38.27% |
| Dec 29, 2023 | 5.96B | -37.68% |
| Dec 30, 2022 | 9.56B | -26.49% |
| Dec 1, 2022 | 13.00B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CellSource | 7.07B |
| ADR Biomedical Holdings | 6.82B |
| Chiome Bioscience | 6.63B |
| Chordia Therapeutics | 6.34B |
| PRISM BioLab Co.,LTD | 6.28B |
| Noile-Immune Biotech | 6.25B |
| Soiken Holdings | 5.75B |
| D. Western Therapeutics Institute | 5.06B |